FutureBridge invites you to their event

Early-stage NSCLC Landscape: How the next decade looks like?

About this event

The landscape of advanced/metastatic NSCLC has changed dramatically with the approval of immunotherapies and targeted agents in recent years. After metastatic disease, early-stage NSCLC has become a new testing ground for these therapies. Most key players are in the race to position their drugs in this hitherto unexplored territory where surgery, radiotherapy (RT), or chemoradiation (ChemoRT) has remained the mainstay of treatment.

Let's together explore how early-stage NSCLC is shaping up with the entrenchment of new therapies and what new questions have emerged with this paradigm shift. FutureBridge’s Oncology Analysts in this webinar will cover the:

  • Current treatment available for early-stage NSCLC, and therapies likely to emerge in the next 5-7 years
  • Recent approvals for IO's, and targeted therapies in early-stage NSCLC. How they have impacted survival?
  • Endpoints appropriate for approvals in early-stage NSCLC
  • How therapies could be combined or sequenced to derive maximum benefit?
  • Who should be the candidates for neoadjuvant vs. adjuvant treatments in the same settings?
  • What is the impact on patient flow and choice of subsequent therapy?
  • What are the residual unmet needs?

Hosted by

  • Team member
    Ankita Malik Consultant @ FutureBridge

    A molecular biologist with expertise in oncology business research and consulting, R&D strategy, and competitive and treatment landscapes for companies developing oncology assets.

  • Team member
    Nidhi Dhingra Director, Oncology @ FutureBridge

    I am life sciences professional with ~20 years overall experience in drug discovery, pharma, oncology/immuno-oncology consulting. I provide consultation to global clients to support their strategic business decisions.


Be the Future.

FutureBridge is a techno-commercial consulting and advisory company.

We track and advise on the future of industries from a 1-to-25-year perspective to keep you ahead of the technology curve, propel your growth, Identify new opportunities, markets and business models, answer your unknowns, and fac